Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
OMNICARE INC
SIC 5912 · Retail-Drug Stores And Proprietary Stores
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
OMNICARE INC
SIC 5912 · Retail-Drug Stores And Proprietary Stores
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
OMNICARE INC
SIC 5912 · Retail-Drug Stores And Proprietary Stores
Notes
Support
about
terms
OMNICARE INC
CIK:
0000353230
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.2.0.727
CONSOLIDATED STATEMENTS OF INCOME UNAUDITED - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenue, Net
$ 1,733,317
$ 1,610,584
$ 3,393,159
$ 3,181,622
Cost of sales
1,379,386
1,256,354
2,689,765
2,468,938
Gross profit
353,931
354,230
703,394
712,684
Selling, general and administrative expenses
168,710
184,063
336,133
370,876
Provision for doubtful accounts
19,184
21,090
38,375
42,651
Settlement, litigation and other related charges
57,702
7,547
67,522
14,599
Other charges
11,405
11,284
12,454
21,560
Operating income
96,930
130,246
248,910
262,998
Interest expense, net of investment income
(27,378)
(29,980)
(55,027)
(59,421)
Income before income taxes
69,552
100,266
193,883
203,577
Income tax (benefit) expense
35,582
39,020
82,524
78,693
Income from continuing operations
33,970
61,246
111,359
124,884
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
0
(39,275)
0
(39,139)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
$ 33,970
$ 21,971
$ 111,359
$ 85,745
Earnings (loss) per common share - Basic:
Income (Loss) from Continuing Operations, Per Basic Share
$ 0.35
$ 0.63
$ 1.15
$ 1.28
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
0.00
(0.40)
0.00
(0.40)
Net income
0.35
0.23
1.15
0.88
Earnings (loss) per common share - Diluted:
Income (Loss) from Continuing Operations, Per Diluted Share
0.32
0.58
1.07
1.17
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share
0.00
(0.37)
0.00
(0.37)
Diluted earnings per share
0.32
0.21
1.07
0.80
Dividends per common share
$ 0.22
$ 0.20
$ 0.44
$ 0.40
Weighted average number of common shares outstanding:
Weighted Average Number of Shares Outstanding, Basic
96,255
96,999
96,487
97,777
Diluted shares
105,212
106,054
104,203
106,906
Comprehensive income (loss)
$ 35,012
$ 22,015
$ 112,551
$ 86,012
v3.2.0.727
CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Loss from disposition
$ 0
$ (520)
Gains (Losses) on Extinguishment of Debt
0
(8,414)
Cash flows from operating activities:
Net income (loss)
111,359
85,745
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
0
39,139
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation expense
29,616
28,277
Amortization expense
36,119
38,820
Changes in assets and liabilities, net of effects from acquisition and divestiture of businesses:
Accounts receivable, net of provision for doubtful accounts
(48,613)
(14,436)
Inventories
42,669
104,580
Other current and noncurrent assets
121,376
(10,418)
Accounts payable
74,092
71,429
Accrued employee compensation
9,433
12,851
Current and noncurrent liabilities
54,294
25,299
Net cash flows from operating activities of continuing operations
430,345
390,220
Net cash flows from operating activities of discontinued operations
0
6,160
Net cash flows from operating activities
430,345
396,380
Cash flows from investing activities:
Acquisition of businesses, net of cash received
(54,802)
0
Proceeds from Divestiture of Businesses
0
7,114
Capital expenditures
(27,664)
(48,023)
Payments for (Proceeds from) Other Investing Activities
0
40
Net cash flows used in investing activities of continuing operations
(82,466)
(40,869)
Net cash flows used in investing activities of discontinued operations
0
(730)
Net cash flows used in investing activities
(82,466)
(41,599)
Cash flows from financing activities:
Payments on Term Loans
(10,000)
(10,625)
Payments on long-term borrowings and obligations
(5,999)
(175,115)
Payments of Debt Issuance Costs
(2,239)
0
Increase (decrease) in cash overdraft balance
1,292
(6,870)
Payments for Omnicare common stock repurchases
(125,000)
(160,438)
Proceeds for stock awards and exercise of stock options, net of stock tendered in payment
(8,224)
(2,720)
Dividends paid
(42,362)
(38,979)
Other
5,562
4,121
Net Cash Provided by (Used in) Financing Activities
(186,970)
(390,626)
Net increase (decrease) in cash and cash equivalents
160,909
(35,845)
Increase (decrease) in cash and cash equivalents of discontinued operations
0
5,430
Increase (decrease) in cash and cash equivalents of continuing operations
160,909
(41,275)
Cash and cash equivalents at beginning of period
153,799
356,001
Cash and cash equivalents at end of period
$ 314,708
$ 314,726
v3.2.0.727
CONSOLIDATED BALANCE SHEETS UNAUDITED - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Current assets:
Cash and cash equivalents
$ 314,708
$ 153,799
Accounts receivable, less allowances of $221,736 (2014 - 201,875)
616,862
578,761
Inventories
477,510
519,584
Deferred income tax benefits
77,400
59,200
Other current assets
187,683
287,560
Total current assets
1,674,163
1,598,904
Properties and equipment, at cost less accumulated depreciation of $361,246 (2014-$332,684)
269,161
267,753
Goodwill
4,094,247
4,061,806
Identifiable intangible assets, less accumulated amortization of $270,446 (2014-$257,283)
112,412
98,942
Other noncurrent assets
70,626
80,385
Total noncurrent assets
4,546,446
4,508,886
Total assets
6,220,609
6,107,790
Current liabilities:
Accounts payable
295,953
219,358
Accrued employee compensation
56,007
46,830
Debt, Current
451,184
446,717
Other current liabilities
213,638
154,726
Total current liabilities
1,016,782
867,631
Long-term debt, net
1,507,422
1,517,559
Deferred income tax liabilities
952,282
936,247
Other noncurrent liabilities
48,457
45,926
Total noncurrent liabilities
2,508,161
2,499,732
Total liabilities
3,524,943
3,367,363
Convertible Debt (Note 5)
145,034
151,706
Stockholders' equity:
Preferred stock, no par value, 1,000,000 shares authorized, none issued and outstanding
0
0
Common stock, $1 par value, 200,000,000 shares authorized, 138,864,312 shares issued (2014,138,425,862 shares issued)
138,864
138,426
Paid in capital
2,254,692
2,210,526
Retained earnings
1,825,686
1,757,386
Treasury stock, at cost- 41,975,706 shares (2014-39,997,930 shares )
(1,666,977)
(1,514,792)
Accumulated Other Comprehensive Income (Loss), Net of Tax
(1,633)
(2,825)
Total stockholders' equity
2,550,632
2,588,721
Total liabilities and stockholders' equity
$ 6,220,609
$ 6,107,790